Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Stanford University
With
Oregon Health and Science University
University of California, San Francisco
University of California, Davis
Case Western Reserve University
Dartmouth-Hitchcock Medical Center
University of Pennsylvania
University of Miami
Wills Eye Hospital
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Dysfunctional endothelium from Fuchs Endothelial Corneal Dystrophy (FECD) with guttata extending beyond 4.5 mm of the central cornea or severe edema without visualization of guttata
Dysfunctional endothelium from Pseudophakic Corneal Edema (PCE) or Iridocorneal Endothelial Syndrome (ICE) or other primary endothelial dysfunction such as Posterior Polymorphous Corneal Dystrophy (PPMD)
Dysfunctional endothelium from prior graft failure after PKP or EK
Controlled uveitis (defined as quiet for \> 3 months off of topical steroids with or without systemic immunosuppression) or no uveitis
Controlled glaucoma with topical medications and/or prior trabeculectomy or tube shunt without ongoing hypotony (IOP \< 5 mmHg) or no glaucoma
Good candidate for corneal transplantation for either DMEK or UT-DSAEK
Willingness to participate
Age greater than 18 years
You may not be if
Aphakia, or anterior chamber IOL or scleral fixated IOL in study eye prior to or anticipated during EK
Pre-operative central sub-epithelial or stromal scarring that the investigator believes is visually significant and could impact post-operative stromal clarity assessment
Peripheral anterior synechiae (iris to angle) in the angle greater than a total of three clock hours
Visually significant optic nerve (ok to have small visual field defects) or macular severe pathology
